Access to anti-retroviral drugs, female in Sweden
Sweden: Access to anti-retroviral drugs, female was 96.0% in 2022. ▲ Rising
Access to anti-retroviral drugs, female in Sweden, 2000–2022
Source: UNAIDS estimates. Measured in %.
Analysis
In 2022, access to anti-retroviral drugs, female in Sweden stood at 96.0%.
Compared with earlier readings it is up 1.1% on the previous year and up 15.7% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Sweden peaked at 97.0% in 2019 and was at its lowest, 24.0%, in 2000.
That places Sweden 14th out of 141 countries with data for 2022, putting it in the top 10%.
The long-run direction has been consistently rising across the 23 years of available data.
Access to anti-retroviral drugs, female in Sweden, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 24.0% | — |
| 2001 | 25.0% | +4.2% |
| 2002 | 27.0% | +8.0% |
| 2003 | 33.0% | +22.2% |
| 2004 | 37.0% | +12.1% |
| 2005 | 39.0% | +5.4% |
| 2006 | 44.0% | +12.8% |
| 2007 | 54.0% | +22.7% |
| 2008 | 65.0% | +20.4% |
| 2009 | 71.0% | +9.2% |
| 2010 | 77.0% | +8.5% |
| 2011 | 80.0% | +3.9% |
| 2012 | 83.0% | +3.8% |
| 2013 | 87.0% | +4.8% |
| 2014 | 91.0% | +4.6% |
| 2015 | 93.0% | +2.2% |
| 2016 | 95.0% | +2.2% |
| 2017 | 96.0% | +1.1% |
| 2018 | 96.0% | +0.0% |
| 2019 | 97.0% | +1.0% |
| 2020 | 96.0% | -1.0% |
| 2021 | 95.0% | -1.0% |
| 2022 | 96.0% | +1.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 41.9% | 24.0% | 71.0% | 10 |
| 2010s | 89.5% | 77.0% | 97.0% | 10 |
| 2020s | 95.7% | 95.0% | 96.0% | 3 |
Countries ranked near Sweden
More gender data for Sweden
- Child population (UN estimates and projections) 1,663 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -1.5 % change on previous year (2030)
- Population 9,179 (2030)
- Working-age population (UN estimates and projections) 9,179 (2030)
- Population (UN estimates and projections), annual growth rate 0.6078 % change on previous year (2030)
- Age population, age 00, female, interpolated 47,810 (2025)
- Age population, age 00, male, interpolated 50,483 (2025)
- Age population, age 01, female, interpolated 48,381 (2025)
- Age population, age 01, male, interpolated 51,112 (2025)
- Age population, age 02, female, interpolated 50,315 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Sweden?
- Access to anti-retroviral drugs, female in Sweden was 96.0% in 2022, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Sweden?
- The highest recorded value was 97.0% in 2019.
- What is the lowest access to anti-retroviral drugs, female recorded in Sweden?
- The lowest recorded value was 24.0% in 2000.
- How does Sweden rank for access to anti-retroviral drugs, female?
- Sweden ranks 14th out of 141 countries with data for 2022.
- Is access to anti-retroviral drugs, female rising or falling in Sweden?
- Over the last ten years it is up 15.7%. The long-run trend across the full record is rising.
- Where does this Sweden data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 23 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.